北美生物生产市场预测至 2030 年 - 区域分析 - 按产品（生物制剂和生物仿制药、疫苗、细胞和基因疗法、核酸疗法等）、应用（类风湿性关节炎、血液病、癌症、糖尿病、心血管疾病等）、设备（上游设备、下游设备、生物反应器、消耗品和配件）和最终用户（生物制药公司、合同制造组织等）
再生药物的日益普及推动了北美生物生产市场的发展
再生疗法有助于细胞、组织和器官的再生以恢复其功能。每年都会向美国食品药品监督管理局 (FDA) 提交大量用于人体临床试验的再生医学申请。根据再生医学联盟的数据，2019 年（第三季度），全球正在进行 1,052 项利用再生医学的临床试验； 2019 年，共有 218 项细胞疗法试验正在进行中（41 项 I 期试验、147 项 II 期试验、30 项 III 期试验）。再生医学正在迅速发展，为慢性病提供有效的解决方案。细胞疗法是再生医学领域增长最快的领域之一。诺华的 Kymriah 是首个用于治疗 B 细胞急性白血病的细胞疗法解决方案。此外，再生医学提供商 RepliCel 拥有广泛的再生医学产品，其中三种产品 RCH-01、RCS-01 和 RCT-01 处于开发阶段。此外，Sernova 致力于再生医学技术的开发，拥有大量针对糖尿病、血友病 A 和甲状腺功能亢进等疾病的产品。因此，再生医学的日益普及正在推动生物生产市场的发展。
北美生物生产市场概览
北美生物生产市场细分为美国、加拿大和墨西哥。在墨西哥，由于干细胞治疗医疗旅游的兴起，对细胞治疗的需求相当可观。由于糖尿病和不孕症的发病率不断上升，以及生物仿制药产品的不断开发，北美生物生产市场在 2022 年占据了最大的市场份额。
遗传和细胞疾病的发病率不断上升，导致对细胞疗法的需求不断增加。2020 年 PhRMA 关于细胞和基因治疗管道的报告显示，美国有 400 种细胞和基因疗法正在开发中，以针对从癌症到遗传疾病再到神经系统疾病的各种疾病和病症。截至 2020 年 2 月，美国已批准 9 种细胞或基因治疗产品，用于治疗癌症、眼部疾病和罕见遗传性疾病。此外，越来越多的初创企业正在该国创新细胞疗法。
北美生物生产市场收入及预测至 2030 年（百万美元）
北美生物生产市场细分
北美生物生产市场分为产品、应用、设备、最终用户和国家。
根据产品，北美生物生产市场细分为生物制剂和生物仿制药、疫苗、细胞和基因疗法、核酸疗法等。生物制剂和生物仿制药部分在 2022 年占据了北美生物生产市场的最大份额。
在应用方面，北美生物生产市场细分为类风湿性关节炎、血液病、癌症、糖尿病、心血管疾病等。癌症部分在 2022 年占据了北美生物生产市场的最大份额。
按设备划分，北美生物生产市场分为上游设备、下游设备、生物反应器以及耗材和配件。 2022 年，耗材和配件部门占据了北美生物生产市场的最大份额。
就最终用户而言，北美生物生产市场分为生物制药公司、合同制造组织和其他。2022 年，生物制药公司部门占据了北美生物生产市场的最大份额。
按国家/地区划分，北美生物生产市场分为美国、加拿大和墨西哥。2022 年，美国占据了北美生物生产市场份额的主导地位。
Bio-Rad Laboratories Inc、Danaher Corp、F. Hoffmann-La Roche Ltd、Lonza Group AG、Merck KGaA、Sartorius AG 和 Thermo Fisher Scientific Inc. 是北美生物生产市场的一些领先公司。
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Bioproduction Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Adoption of Regenerative Medicines
4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis
5. Bioproduction Market - North America Market Analysis
5.1 North America Bioproduction Market Revenue (US$ Mn), 2020 – 2030
6. North America Bioproduction Market – Revenue and Forecast to 2030 – by Product
6.1 Overview
6.2 North America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
6.3.1 Overview
6.3.2 Biologics and Biosimilars: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
6.4.1 Overview
6.4.2 Vaccines: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
6.5.1 Overview
6.5.2 Cell and Gene Therapies: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
6.6.1 Overview
6.6.2 Nucleic Acid Therapeutics: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7. North America Bioproduction Market – Revenue and Forecast to 2030 – by Application
7.1 Overview
7.2 North America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
7.3.1 Overview
7.3.2 Cancer: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
7.5.1 Overview
7.5.2 Rheumatoid Arthritis: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
7.6.1 Overview
7.6.2 Hematological Disorders: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
7.7.1 Overview
7.7.2 Diabetes: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8. North America Bioproduction Market – Revenue and Forecast to 2030 – by Equipment
8.1 Overview
8.2 North America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
8.3.1 Overview
8.3.2 Consumables and Accessories: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
8.4.1 Overview
8.4.2 Downstream Equipment: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
8.5.1 Overview
8.5.2 Bioreactors: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 North America: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
8.6 Upstream Equipment
8.6.1 Overview
8.6.2 Upstream Equipment: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Bioproduction Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 North America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Biopharmaceutical Companies: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
9.4.1 Overview
9.4.2 Contract Manufacturing Organizations: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Bioproduction Market – Revenue and Forecast to 2030 – Country Analysis
10.1 North America: Bioproduction Market
10.1.1 US: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1 Overview
10.1.1.2 US: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3 US: Bioproduction Market, by Product, 2020–2030 (US$ Million)
10.1.1.4 US: Bioproduction Market, by Application, 2020–2030 (US$ Million)
10.1.1.5 US: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
10.1.1.5.1 US: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
10.1.1.6 US: Bioproduction Market, by End User, 2020–2030 (US$ Million)
10.1.1.2 Canada: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Canada: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Canada: Bioproduction Market, by Product, 2020–2030 (US$ Million)
10.1.1.2.4 Canada: Bioproduction Market, by Application, 2020–2030 (US$ Million)
10.1.1.2.5 Canada: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
10.1.1.2.5.1 Canada: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
10.1.1.2.6 Canada: Bioproduction Market, by End User, 2020–2030 (US$ Million)
10.1.1.3 Mexico: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 Mexico: Bioproduction Market, by Product, 2020–2030 (US$ Million)
10.1.1.3.4 Mexico: Bioproduction Market, by Application, 2020–2030 (US$ Million)
10.1.1.3.5 Mexico: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
10.1.1.3.5.1 Mexico: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
10.1.1.3.6 Mexico: Bioproduction Market, by End User, 2020–2030 (US$ Million)
11. Bioproduction Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Lonza Group AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Danaher Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sartorius AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck KGaA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 F. Hoffmann-La Roche Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bio-Rad Laboratories Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
List of Tables
Table 1. North America Bioproduction Market Segmentation
Table 2. North America Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 3. US Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 4. US Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 5. US Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 6. US Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 7. US Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 8. Canada Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 12. Canada Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 14. Mexico Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 17. Mexico Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 18. Recent Inorganic Growth Strategies in the Bioproduction Market
Table 19. Recent Organic Growth Strategies in the Bioproduction Market
Table 20. Glossary of Terms, Bioproduction Market
List of Figures
Figure 1. North America Bioproduction Market Segmentation, By Country
Figure 2. North America Bioproduction Market: Key Industry Dynamics
Figure 3. North America Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 4. North America Bioproduction Market Revenue (US$ Mn), 2020 – 2030
Figure 5. North America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Biologics and Biosimilars: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Vaccines: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell and Gene Therapies: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nucleic Acid Therapeutics: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. North America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Cancer: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Rheumatoid Arthritis: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hematological Disorders: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. North America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 19. Consumables and Accessories: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Downstream Equipment: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Bioreactors: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Upstream Equipment: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Biopharmaceutical Companies: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Contract Manufacturing Organizations: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. North America: Bioproduction Market, by Key Country – Revenue (2022) (US$ Million)
Figure 28. North America: Bioproduction Market, by Country, 2022 & 2030 (%)
Figure 29. US: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Canada: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Mexico: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. Growth Strategies in the Bioproduction Market
1. Bio-Rad Laboratories Inc
2. Danaher Corp
3. F. Hoffmann-La Roche Ltd
4. Lonza Group AG
5. Merck KGaA
6. Sartorius AG
7. Thermo Fisher Scientific Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America bioproduction market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America bioproduction market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America bioproduction market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.